Mounjaro Alternatives: Options, Cost, and How to Choose
Mounjaro® (tirzepatide, Eli Lilly) is FDA-approved for type 2 diabetes, and its use for weight loss is common but off-label - Zepbound is the version specifically approved for weight management. Either way, without insurance, brand-name tirzepatide commonly lists at $1,000+ a month. Here’s what your alternatives look like.
Compounded tirzepatide
The most direct alternative is compounded tirzepatide - the same active ingredient as Mounjaro and Zepbound, prepared by a licensed compounding pharmacy. A licensed provider reviews your health history and determines whether treatment is appropriate before prescribing. It’s not FDA-approved and not a generic, substitute, or equivalent of Mounjaro, but it’s a legal, regulated option many patients use specifically for the cost difference.
Semaglutide (Ozempic / Wegovy)
Semaglutide is a related but different medication - it acts on one hormone pathway (GLP-1) instead of tirzepatide’s two (GLP-1 and GIP). Some patients and providers consider tirzepatide for its dual mechanism, but the right option depends on your individual health history. Compare the two: semaglutide vs. tirzepatide.
What drives the price difference
Brand-name tirzepatide’s list price reflects manufacturer R&D, marketing, and distribution costs. A compounding pharmacy prepares the same active ingredient at a fraction of that overhead. Full breakdown: tirzepatide cost without insurance.
How Renlo’s pricing compares
Renlo’s compounded tirzepatide is $269/month ($233/month on the 3-month plan), including your provider consultation, medication, supplies, shipping, and ongoing care team support - no membership fee, no insurance required, and the price stays flat as your dose increases. See current pricing.
Getting started
Complete a short online intake and a licensed provider typically reviews it within 12 hours. If approved, medication ships from a licensed U.S. pharmacy; if not, you get a full refund. Start your assessment to see if you qualify.
This article is for general educational purposes only and is not medical advice. Mounjaro, Zepbound, Ozempic, and Wegovy are trademarks of their respective owners; references are for comparison and informational purposes only. Renlo’s compounded medications are not FDA-approved and are not generics, substitutes, or equivalents of any brand-name medication. Pricing changes over time - always confirm current terms directly with any provider.
Frequently asked questions
What is a good alternative to Mounjaro?
Compounded tirzepatide - the same active ingredient as Mounjaro, prepared by a licensed compounding pharmacy - is the most direct alternative. Zepbound is the same molecule marketed specifically for weight management, and semaglutide (Ozempic/Wegovy) is a related but different option.
Is compounded tirzepatide the same as Mounjaro?
Compounded tirzepatide contains the same active pharmaceutical ingredient as Mounjaro, but it is prepared by a compounding pharmacy rather than the original manufacturer, is not FDA-approved, and is not a generic, substitute, or equivalent of Mounjaro.
Is Mounjaro the same as Zepbound?
Mounjaro and Zepbound both contain tirzepatide, made by the same manufacturer, but they're approved and marketed for different uses - Mounjaro for type 2 diabetes and Zepbound for chronic weight management.
How much does a Mounjaro alternative cost through Renlo?
Renlo's compounded tirzepatide is $269/month on the monthly plan, or $233/month on the 3-month plan, with the provider consultation, medication, supplies, and shipping all included.